Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches -- Ignore unavailable to you. Want to Upgrade?

To: carranza2 who wrote (39340)	12/16/2025 8:14:14 AM
From: carranza2	1 Recommendation Recommended By DinoNavarre Respond to of 39344

The Google Ai response on fish oil and atrial fibrillation did not satisfy my quest for more detail so I took it to Grok 4, a much better Ai tool: Evidence from randomized controlled trials (RCTs) and meta-analyses indicates a dose-dependent relationship between fish oil supplementation (providing omega-3 fatty acids, primarily EPA and DHA) and the risk of developing atrial fibrillation (AF). Higher doses generally associate with greater risk, while lower doses show minimal or no significant increase. High-Dose Supplementation (>1 g/day EPA+DHA) Trials using doses of 1.8–4 g/day (e.g., REDUCE-IT, STRENGTH, OMEMI) report significantly elevated AF risk, with hazard ratios (HR) ranging from 1.35 to 1.69. Meta-analyses of RCTs confirm this pattern: • Overall increased AF risk (incidence rate ratio ~1.25–1.37). • Stronger effect at higher doses (HR 1.49 for >1 g/day vs. HR 1.12 for =1 g/day). Meta-regression shows a linear dose-response: HR increases by ~1.09–1.11 per additional 1 g/day (over 1–4 g/day range). Pharmaceutical/high-dose supplementation raises risk by ~50% at 1.8–4 g/day, versus ~12% at ~1 g/day. Low-Dose Supplementation (=1 g/day) Trials (e.g., VITAL, ASCEND) find no significant AF risk increase. Typical over-the-counter fish oil supplements often fall in this range and show lower concern. Dietary Intake vs. Supplements Observational data and biomarker studies (e.g., circulating omega-3 levels) often show an inverse association—moderate dietary intake from fish (~650–750 mg/day EPA+DHA) links to reduced AF risk (~11–12% lower). In the UK Biobank, higher plasma omega-3 levels associated with lower AF incidence, while self-reported fish oil supplement use showed no significant risk after adjustments (likely due to predominantly lower doses). A proposed mechanism involves vagal tone: moderate omega-3 increases provide protective low-level vagal stimulation, while high doses cause excessive stimulation that promotes AF. The absolute risk increase from supplementation is generally low, but the dose-dependent pattern is consistent across recent analyses (up to 2025). Individuals considering fish oil—especially at higher doses—should discuss risks with a healthcare provider, particularly if they have cardiovascular risk factors. Dietary sources (e.g., fatty fish) appear safer for omega-3 intake regarding AF risk.

To: carranza2 who wrote (39340)	12/16/2025 7:04:04 PM
From: Stan	1 Recommendation Recommended By DinoNavarre Respond to of 39344

Same question to ChatGPT (upgraded version @ $19.99 a month - using it temporarily for some medical problems): Prompt - Can high daily doses of fish oil cause problems? Yes. High daily doses of fish oil (omega-3 fatty acids: EPA/DHA) can cause problems, especially when taken long-term or above commonly recommended ranges. Below is a practical, evidence-based breakdown. Generally accepted dose ranges Typical health dose: 250–1,000 mg/day of combined EPA + DHA Prescription-level doses: 2–4 g/day EPA/DHA (used for high triglycerides under medical supervision) Problems become more likely as you approach or exceed ~3–4 g/day, especially without clinician oversight. Potential problems from high daily doses 1. Increased bleeding risk Fish oil has antiplatelet (blood-thinning) effects. Risks increase if: 3 g/day EPA/DHA Combined with aspirin, clopidogrel, warfarin, DOACs, NSAIDs You have recent surgery, GI ulcers, or bleeding disorders Signs to watch for: Easy bruising Nosebleeds Bleeding gums Blood in stool or urine 2. Atrial fibrillation (AFib) risk (important) Large clinical trials (2020–2023) showed: High-dose omega-3s (=4 g/day) were associated with a higher risk of atrial fibrillation, especially in older adults and those with heart disease. This does not apply to low or moderate doses. 3. Gastrointestinal issues Common and dose-related: Reflux / heartburn Nausea Diarrhea Fishy burps More likely if: Taken on an empty stomach Liquid or poorly purified products 4. LDL cholesterol may rise While triglycerides usually drop: LDL can increase (particularly with DHA-heavy formulas) Relevant if cardiovascular risk is already high 5. Immune modulation (theoretical but relevant at very high doses) At high chronic doses: Omega-3s can suppress aspects of immune function Usually only a concern with very high, prolonged dosing 6. Vitamin A toxicity (with cod liver oil) This is not from standard fish oil. Cod liver oil contains vitamin A: Chronic high intake ? liver toxicity, bone loss, headaches Who should be especially cautious People on blood thinners or antiplatelet drugs History of atrial fibrillation Recent or upcoming surgery Chronic liver disease High fall or injury risk (relevant for wheelchair and other walking-aid users) Practical guidance =1 g/day EPA+DHA ? generally very safe for long-term use 1–3 g/day ? usually safe but review meds =3–4 g/day ? medical supervision recommended Also: Check the actual EPA + DHA content, not just “1,000 mg fish oil” Take with meals Choose third-party tested products (USP, IFOS) If you’d like, tell me: Your daily dose Reason for taking it (heart, inflammation, joints, cognition, etc.) Other meds or supplements I can help you decide whether the dose makes sense or should be adjusted.